Roche invests in peptide technology

Tuesday 31 August 2010

The Roche Group has announced plans to invest $25 million upfront for access to new peptide technology that locks peptides into their biologically active shape, mimicking the structures found in nature.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland